Professor Naomi Allen
BSc, MSc, DPhil
Professor in Epidemiology
- Clinical Trial Service Unit
Naomi Allen is a Professor in Epidemiology, based in the Clinical Trial Service Unit and Epidemiological Studies Unit. She joined UK Biobank as Senior Epidemiologist in 2011, and became Chief Scientist in 2019, where she is responsible for following-up participants both through linkage with routine health-related datasets, and through web-based questionnaires. She is also involved in developing the scientific strategy for future enhancements for the study. Her research interest is largely in the role of diet, obesity and circulating biomarkers in cancer development. She is co-Principal Investigator of the Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group, which aims to conduct individual pooled analyses of the relationship between circulating biomarkers and prostate cancer risk from cohort studies from around the world.
Prospective analysis of circulating metabolites and endometrial cancer risk.
Dossus L. et al, (2021), Gynecol Oncol
Characterization of human papillomavirus (HPV) 16 E6 seropositive individuals without HPV-associated malignancies after 10 years of follow-up in the UK Biobank.
Brenner N. et al, (2020), EBioMedicine, 62
Circulating insulin-like growth factor-I, total and free testosterone concentrations and prostate cancer risk in 200 000 men in UK Biobank.
Watts EL. et al, (2020), Int J Cancer
Genetic, lifestyle, and health-related characteristics of adults without celiac disease who follow a gluten-free diet: a population-based study of 124,447 participants.
Littlejohns TJ. et al, (2020), Am J Clin Nutr
Adiposity and Endometrial Cancer Risk in Postmenopausal Women: A Sequential Causal Mediation Analysis.
Dashti SG. et al, (2020), Cancer Epidemiol Biomarkers Prev